Kiniksa Pharmaceuticals, Ltd.
3 clinical trials · Sponsor
◉ Watch Kiniksa Pharmaceuticals, Ltd.
| Record | Firm | Date |
|---|---|---|
| Study to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to at Least One Biologic Disease-modifying Anti-rheumatic Drug or a Janus Kinase Inhibitor (NCT05198310) | Kiniksa Pharmaceuticals, Ltd. | 2021-12-14 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of KPL-404 in Healthy Subjects (NCT04497662) | Kiniksa Pharmaceuticals, Ltd. | 2019-10-22 |
| KPL-301 for Subjects With Giant Cell Arteritis (NCT03827018) | Kiniksa Pharmaceuticals, Ltd. | 2018-09-20 |
Track Kiniksa Pharmaceuticals, Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.